JASPER THERAPEUTICS, INC.JSPRW -1.5
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
Name | Value |
---|
Revenues | 0.0M |
Cost of Revenue | 0.3M |
Gross Profit | -0.3M |
Operating Expense | 14.8M |
Operating I/L | -15.1M |
Other Income/Expense | 1.3M |
Interest Income | 1.4M |
Pretax | -13.7M |
Income Tax Expense | 0.2M |
Net Income/Loss | -13.7M |
Jasper Therapeutics, Inc.
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.